About Michael Stratton
Sir Michael Rudolf Stratton is a British clinical scientist and the third director of the Wellcome Trust Sanger Institute. He currently heads the Cancer Genome Project and is a leader of the International Cancer Genome Consortium. In 2002 and 2004, Stratton's team discovered mutations in the BRAF and ERBB2 genes in approximately 60 per cent of melanomas and 4 per cent of non-small-cell lung cancers respectively. In 2009, Stratton and colleagues reported the first complete cancer genomes, from a lung tumour and a melanoma. In May 2022, Stratton was awarded the inaugural 'In Search of Wonder Lifetime Achievement Award' at the Cambridge Independent's Science and Technology Awards, sponsored by Waterbeach creative design agency JDJ Creative. He obtained a PhD while working on Medulloblastomas in the molecular biology of cancer at the Institute of Cancer Research, awarded by the University of London in 1990.
Biography source: Wikipedia. The profile adds birthday-specific historical context from the Celebs Birthday Today editorial database.